Drug Testing Locations - New Brunswick, NJ

Drug Testing in New Brunswick, NJ

New Brunswick, New Jersey Statistics

In 2020, Middlesex County reported 570 opioid-related overdose cases, a significant concern for New Brunswick, its largest city.

New Brunswick saw a 14% increase in drug-related emergency department visits in 2019 compared to previous years.

The rate of substance abuse treatment admissions in Middlesex County was 1,180 per 100,000 population in 2021.

In 2018, New Brunswick accounted for approximately 15% of Middlesex County's total drug arrests.

A 2021 survey found that 8% of high school students in New Brunswick reported using illicit drugs in the past month.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New Brunswick, NJ & Drug Testing Policies

Several major employers in New Brunswick, NJ have implemented strict drug testing policies to ensure a safe and productive work environment. These policies typically include pre-employment screenings as well as random or scheduled tests to deter drug use among employees.

New Jersey’s Department of Labor and Workforce Development provides guidelines that help organizations create fair and legally compliant drug testing policies. This ensures workplaces can maintain safety standards while respecting employee rights.

The city also encourages employers to offer Employee Assistance Programs (EAPs) that provide resources and support for employees struggling with substance abuse, fostering a supportive culture that prioritizes health and well-being.

Government Efforts with Drug Problems in New Brunswick, NJ

The government of New Brunswick, NJ, in conjunction with Middlesex County, actively addresses drug problems through prevention and intervention programs. Key among these initiatives is the New Jersey Office of the Attorney General, which works to combat opioid usage with targeted campaigns and funding support.

Local agencies, such as the Middlesex County Department of Community Services, provide educational programs and resources to curb substance abuse. Emphasis is placed on partnerships with schools and community organizations to raise awareness and provide support to affected individuals and families.

Local Drug Busts & News in New Brunswick, NJ

Recent drug busts in New Brunswick, NJ, have spotlighted the ongoing efforts of local law enforcement to combat illegal narcotics. Task forces have focused on curbing the distribution of substances like heroin and fentanyl, which continue to affect the community. These operations often involve collaboration with state and federal agencies to dismantle distribution networks operating in the area.

The strategic location of New Brunswick has made it a focal point for drug trafficking routes. Law enforcement has deployed various techniques, including surveillance and undercover operations, to identify and apprehend key figures in these networks. Recent arrests have led to the confiscation of significant quantities of drugs, highlighting the scope of the issue.

Community involvement has been crucial in addressing the drug problem in New Brunswick. Local organizations have partnered with law enforcement to raise awareness and provide support to those struggling with addiction. Educational programs and outreach initiatives aim to prevent drug abuse by informing young people about the risks associated with substance use.

Despite the challenges, there have been some notable successes in reducing drug-related activities in New Brunswick. Ongoing efforts are focused on both enforcement and prevention to ensure a safer environment for residents. While challenges remain, the community continues to support initiatives aimed at reducing the impact of illegal drugs in the area.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New Brunswick, NJ. Trusted by employers nationwide for accurate results and exceptional service.

New Jersey DOT/Non DOT Physicals

New Jersey Vision Tests

New Jersey Audiograms

New Jersey Respirator Fit Tests

New Jersey Lift Tests

New Jersey Background Checks

Clinical Testing Services

TB Testing in NJ

Diabetes Testing in NJ

Infectious Disease Testing in NJ

Sickle Cell Anemia Testing in NJ

Women/Men's Health Testing in NJ

Resources & Citations

NJ 211

New Jersey Prevention Network

SAMHSA

Partnership for a Drug-Free New Jersey

Middlesex County Resources

National Council on Alcoholism and Drug Dependence - New Jersey

NJ Division of Mental Health and Addiction Services

NJ Recovery Directory

Drug Testing Near New Brunswick, NJ

Sayreville, NJ

Middlebush, NJ

East Brunswick, NJ

South River, NJ

Clyde, NJ

Red Lion, NJ

Middlesex, NJ

Edison, NJ

Piscataway, NJ

North Brunswick Township, NJ

Milltown, NJ

Somerset, NJ

Highland Park, NJ

East Franklin, NJ

Frequently Asked Questions

Customer Reviews